Categories: Health

Director/PDMR Shareholding

 | Source: DXS International PLC

DXS INTERNATIONAL PLC

(AQSE: DXSP)

Notification of Director / PDMR Dealing

DXS INTERNATIONAL PLC

The Board of DXS International plc (the “Company” or “DXSP), the AQSE Growth Market quoted clinical decision support developer and supplier of clinical decision support systems, has received notification that on 30 January, Mr Bob Sutcliffe, the Chairman, purchased 15,000 Ordinary Shares in the Company at a price of 2.9p per share.

Following this transaction Mr Sutcliffe and his wife’s interest in DXS Ordinary Shares is 1,253,756 Ordinary Shares representing 1.96% of the issued share capital of the Company.

1 Details of the person discharging managerial responsibilities / person closely associated
a) Name Mr. Robert Sutcliffe
2 Reason for the notification
a) Position/status Chairman
b) Initial notification /Amendment Initial
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name DXS INTERNATIONAL PLC
b) LEI 2138001R1KEUWTXEVJ44
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of 0.33p each
Identification code ISIN GB00B2Q6HZ92
b) Nature of the transaction Purchase of shares
c) Price(s) and volume(s)
Price(s) Volume(s)
2.9p 15,000
d) Aggregated information
– Aggregated volume
– Price
e) Date of the transaction 30 January 2025
f) Place of the transaction Aquis Stock Exchange

The Directors of DXS International plc accept responsibility for this announcement.

Contacts:

David Immelman
DXS International plc
www.dxs-systems.com
01252 719800
AQSE Corporate Broker and Corporate Advisor
Hybridan LLP
Claire Louise Noyce
020 3764 2341

Notes to Editors

About DXS:
DXS International presents up to date treatment guidelines and recommendations, from Clinical Commissioning Groups and other trusted NHS sources, to doctors, nurses and pharmacists in their workflow and during the patient consultation. This effective clinical decision support ultimately translates to improved healthcare outcomes delivered more cost effectively and which should significantly contribute towards the NHS achieving its projected efficiency savings.

GlobeNews Wire

Recent Posts

President Bach to resign as an IOC Member after 23 June 2025

26 February 2025 - The International Olympic Committee (IOC) Executive Board (EB) today agreed to accept the…

4 hours ago

IOC grants provisional recognition to World Boxing

26 February 2025 - The Executive Board (EB) of the International Olympic Committee (IOC) provisionally recognised World…

4 hours ago

March Mania in Las Vegas is a Slam Dunk with Live Entertainment, CantMiss Watch Parties and Game Day Culinary Delicacies

LAS VEGAS – As the Sports and Entertainment Capital of the World, Las Vegas is…

5 hours ago

Moldova Digital Summit 2025: Accelerating Innovation & Investment in Eastern Europe

CHISINAU, Moldova, Feb. 26, 2025 /PRNewswire/ -- The Moldova Digital Summit (MDS25) returns for its 14th…

7 hours ago

Compass Mining Expands with 20 MW Hydro-Cooled Bitcoin Mining Facility in North Dakota

5.5 MW of the Next-Generation Antminer S21 Hydro Machines Already Energized for Institutional Client WILMINGTON,…

7 hours ago

CoinW Elevates Security Standards and Unveils High-Yield Crypto Earnings

HONG KONG, Feb. 26, 2025 /PRNewswire/ -- In the wake of the recent industrial security…

7 hours ago